← All trials
NCT01908114
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 1, 2013
- Primary completion
- Jun 1, 2014
- Completion date
- Jun 1, 2017
- First posted
- —
- Last posted
- —
- Enrollment
- 60000
- Arms / groups
- 3 / —
- Source
- AACT · pre-existing
Sponsors
- Aga Khan UniversityLead sponsor
- World Health OrganizationCollaborator
- United NationsCollaborator
- Aga Khan UniversityOverall official - principal investigator
- Aga Khan UniversitySponsor investigator
- Trust for Vaccines and Immunization, PakistanCollaborator
- Peshawar Medical CollegeCollaborator
- Bill and Melinda Gates FoundationCollaborator
- Government of PakistanCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.